Voclosporin

(Lupkynis®)

Voclosporin

Drug updated on 11/15/2023

Dosage FormCapsule (oral; 7.9 mg)
Drug ClassCalcineurin inhibitors
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Used in combination with a background immunosuppressive therapy regimen for the treatment of adult patients with active lupus nephritis.